DCT
1:17-cv-00374
Bristol Myers Squibb Co v. Aurobindo Pharma USA Inc
General
Cause of ActionPatent Infringement
SectorBiotech
Status
Closed (08/13/20)
Patent Owner
Operating Company (W)
PACER1:17-cv-00374
CourtD. Delaware
Judge | Period | PO Win Rate |
|---|---|---|
04/12/17 - 10/12/21 | 39% |
MagistrateChristopher J. Burke, Jennifer L. Hall
Plaintiff
Party
Name | Ratings |
|---|---|
L4A | |
L5A |
Attorney
Name | Ratings |
|---|---|
L5A | |
L5A | |
L5A | |
L5A | |
L5B | |
L5B | |
L5D | |
L4A | |
L4B | |
L4B | |
L4B | |
L4C | |
L4D | |
L3A | |
L3D | |
L3D | |
L2E | |
---- -- | |
---- -- | |
---- -- | |
---- -- | |
---- -- | |
Farnan LLPLocal | L4E |
L5E | |
L4E |
Defendant
Party
Name | Ratings |
|---|---|
L4E | |
L5E | |
L5E | |
L5E | |
L5E | |
L5E | |
L5E | |
L4E | |
L4E | |
L4E | |
L3D | |
L3E | |
L3E | |
L3E | |
L3E | |
L3E | |
L3E | |
L2E | |
L2E | |
L2E | |
L2E | |
L2E | |
L1D | |
L1D | |
L1E | |
L1E | |
L1E | |
L1E | |
---- -- |
Attorney
Name | Ratings |
|---|---|
L5A | |
L5B | |
L5B | |
L5A | |
L5A | |
L5A | |
L4D | |
L4E | |
L1D | |
L5A | |
L5A | |
L5A | |
L5D | |
L4B | |
L3C | |
L2B | |
L5C | |
L5B | |
L5D | |
---- -- | |
L4B | |
L5D | |
L5E | |
L4C | |
L4D | |
L4B | |
L5A | |
L5A | |
L5D | |
L5E | |
L4D | |
L3D | |
L3E | |
L2E | |
L4B | |
L5E | |
L4B | |
---- -- | |
L4C | |
L4D | |
L3D | |
Bayard PALocal | L4E |
L5E | |
L4E | |
L5E | |
L4E | |
L3B | |
L3D | |
L3C | |
L5B | |
L4C | |
L4C | |
L3D | |
L3E | |
L2E | |
L1C | |
L3E | |
L4E | |
L3E | |
L3E | |
L3E | |
L5E | |
L5E | |
L5E | |
L4E | |
L4E | |
L3E | |
---- -- | |
L3E | |
L5E | |
L3C | |
L3D | |
L3E | |
L5E | |
L4D | |
L2B | |
L4E | |
L2C | |
L1-- -- | |
L2C | |
L5D | |
L5E | |
L4B | |
L4C | |
L4C | |
L4D | |
L4E | |
L3D | |
L2C | |
L4B | |
L4C | |
L3B | |
Abrams & Bayliss LLPLocal | L2D |
L2E | |
L2E | |
L5D | |
L5E | |
L4D | |
L3E | |
L2E | |
L5C | |
L5E | |
L4D | |
L2E | |
L4E | |
Amin HallihanLocal | L1B |
L1-- -- | |
L1D | |
L4D | |
Attorney at LawLocal | ---- -- |
---- -- | |
---- -- |